Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.
Saved in:
| Title: | Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion. |
|---|---|
| Authors: | Katoh H, Okamoto R, Ozawa Y, Tokito T, Kikuchi M, Sangai T |
| Source: | European thyroid journal [Eur Thyroid J] 2025 Dec 24; Vol. 14 (6). Date of Electronic Publication: 2025 Dec 24 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Bioscientifica Ltd Country of Publication: England NLM ID: 101604579 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2235-0802 (Electronic) Linking ISSN: 22350640 NLM ISO Abbreviation: Eur Thyroid J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41439488 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Katoh+H%22">Katoh H</searchLink><br /><searchLink fieldCode="AU" term="%22Okamoto+R%22">Okamoto R</searchLink><br /><searchLink fieldCode="AU" term="%22Ozawa+Y%22">Ozawa Y</searchLink><br /><searchLink fieldCode="AU" term="%22Tokito+T%22">Tokito T</searchLink><br /><searchLink fieldCode="AU" term="%22Kikuchi+M%22">Kikuchi M</searchLink><br /><searchLink fieldCode="AU" term="%22Sangai+T%22">Sangai T</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101604579%22">European thyroid journal</searchLink> [Eur Thyroid J] 2025 Dec 24; Vol. 14 (6). <i>Date of Electronic Publication: </i>2025 Dec 24 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Bioscientifica+Ltd%22">Bioscientifica Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101604579 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2235-0802 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222350640%22">22350640 </searchLink><i>NLM ISO Abbreviation: </i>Eur Thyroid J <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41439488 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1530/ETJ-25-0377 Languages: – Code: eng Text: English Titles: – TitleFull: Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Katoh H – PersonEntity: Name: NameFull: Okamoto R – PersonEntity: Name: NameFull: Ozawa Y – PersonEntity: Name: NameFull: Tokito T – PersonEntity: Name: NameFull: Kikuchi M – PersonEntity: Name: NameFull: Sangai T IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 12 Text: 2025 Dec 24 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2235-0802 Numbering: – Type: volume Value: 14 – Type: issue Value: 6 Titles: – TitleFull: European thyroid journal Type: main |
| ResultId | 1 |
